| 1. |
- Bonagas, Nadilly, et al.
(författare)
-
Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress
- 2022
-
Ingår i: NATURE CANCER. - : Springer Science and Business Media LLC. - 2662-1347. ; 3:2, s. 156-
-
Tidskriftsartikel (refereegranskat)abstract
- The folate metabolism enzyme MTHFD2 (methylenetetrahydrofolate dehydrogenase/cyclohydrolase) is consistently overexpressed in cancer but its roles are not fully characterized, and current candidate inhibitors have limited potency for clinical development. In the present study, we demonstrate a role for MTHFD2 in DNA replication and genomic stability in cancer cells, and perform a drug screen to identify potent and selective nanomolar MTHFD2 inhibitors; protein cocrystal structures demonstrated binding to the active site of MTHFD2 and target engagement. MTHFD2 inhibitors reduced replication fork speed and induced replication stress followed by S-phase arrest and apoptosis of acute myeloid leukemia cells in vitro and in vivo, with a therapeutic window spanning four orders of magnitude compared with nontumorigenic cells. Mechanistically, MTHFD2 inhibitors prevented thymidine production leading to misincorporation of uracil into DNA and replication stress. Overall, these results demonstrate a functional link between MTHFD2-dependent cancer metabolism and replication stress that can be exploited therapeutically with this new class of inhibitors. Helleday and colleagues describe a nanomolar MTHFD2 inhibitor that causes replication stress and DNA damage accumulation in cancer cells via thymidine depletion, demonstrating a potential therapeutic strategy in AML tumors in vivo.
|
|
| 2. |
- Davies, Jonathan R., et al.
(författare)
-
Structural and Biochemical Characterization of Botulinum Neurotoxin Subtype B2 Binding to Its Receptors
- 2020
-
Ingår i: Toxins. - : MDPI AG. - 2072-6651 .- 2072-6651. ; 12:9
-
Tidskriftsartikel (refereegranskat)abstract
- Botulinum neurotoxins (BoNTs) can be used therapeutically to treat a wide range of neuromuscular and neurological conditions. A collection of natural BoNT variants exists which can be classified into serologically distinct serotypes (BoNT/B), and further divided into subtypes (BoNT/B1, B2, …). BoNT subtypes share a high degree of sequence identity within the same serotype yet can display large variation in toxicity. One such example is BoNT/B2, which was isolated from Clostridium botulinum strain 111 in a clinical case of botulism, and presents a 10-fold lower toxicity than BoNT/B1. In an effort to understand the molecular mechanisms behind this difference in potency, we here present the crystal structures of BoNT/B2 in complex with the ganglioside receptor GD1a, and with the human synaptotagmin I protein receptor. We show, using receptor-binding assays, that BoNT/B2 has a slightly higher affinity for GD1a than BoNT/B1, and confirm its considerably weaker affinity for its protein receptors. Although the overall receptor-binding mechanism is conserved for both receptors, structural analysis suggests the lower affinity of BoNT/B2 is the result of key substitutions, where hydrophobic interactions important for synaptotagmin-binding are replaced by polar residues. This study provides a template to drive the development of future BoNT therapeutic molecules centered on assessing the natural subtype variations in receptor-binding that appears to be one of the principal stages driving toxicity.
|
|
| 3. |
- Dong, Min, et al.
(författare)
-
The Structure and Classification of Botulinum Toxins
- 2021
-
Ingår i: Botulinum Toxin Therapy. - Cham : Springer International Publishing. - 0171-2004. - 9783030663056 ; 263, s. 11-33
-
Bokkapitel (refereegranskat)abstract
- Botulinum neurotoxins (BoNTs) are a family of bacterial protein toxins produced by various Clostridium species. They are traditionally classified into seven major serotypes (BoNT/A-G). Recent progress in sequencing microbial genomes has led to an ever-growing number of subtypes, chimeric toxins, BoNT-like toxins, and remotely related BoNT homologs, constituting an expanding BoNT superfamily. Recent structural studies of BoNTs, BoNT progenitor toxin complexes, tetanus neurotoxin (TeNT), toxin-receptor complexes, and toxin-substrate complexes have provided mechanistic understandings of toxin functions and the molecular basis for their variations. The growing BoNT superfamily of toxins present a natural repertoire that can be explored to develop novel therapeutic toxins, and the structural understanding of their variations provides a knowledge basis for engineering toxins to improve therapeutic efficacy and expand their clinical applications.
|
|
| 4. |
- Gregg, Brieana M., et al.
(författare)
-
Botulinum neurotoxin X lacks potency in mice and in human neurons
- 2024
-
Ingår i: mBio. - 2161-2129 .- 2150-7511. ; 15:3
-
Tidskriftsartikel (refereegranskat)abstract
- Botulinum neurotoxins (BoNTs) are a class of toxins produced by Clostridium botulinum (C. botulinum) and other species of Clostridia. BoNT/X is a putative novel botulinum neurotoxin identified through genome sequencing and capable of SNARE cleavage, but its neurotoxic potential in humans and vertebrates remained unclear. The C. botulinum strain producing BoNT/X, Strain 111, encodes both a plasmid-borne bont/b2 as well as the chromosomal putative bont/x. This study utilized C. botulinum Strain 111 from Japan as well as recombinantly produced full-length BoNT/X to more fully analyze this putative pathogenic toxin. We confirmed production of full-length, catalytically active native BoNT/X by C. botulinum Strain 111, produced as a disulfide-bonded dichain polypeptide similar to other BoNTs. Both the purified native and the recombinant BoNT/X had high enzymatic activity in vitro but displayed very low potency in human-induced pluripotent stem cell-derived neuronal cells and in mice. Intraperitoneal injection of up to 50 µg of native BoNT/X in mice did not result in botulism; however, mild local paralysis was observed after injection of 2 μg into the gastrocnemius muscle. We further demonstrate that the lack of toxicity by BoNT/X is due to inefficient neuronal cell association and entry, which can be rescued by replacing the receptor binding domain of BoNT/X with that of BoNT/A. These data demonstrate that BoNT/X is not a potent vertebrate neurotoxin like the classical seven serotypes of BoNTs.
|
|
| 5. |
- Jemth, Ann-Sofie, et al.
(författare)
-
Nudix hydrolase 18 catalyzes the hydrolysis of active triphosphate metabolites of the antivirals remdesivir, ribavirin, and molnupiravir
- 2022
-
Ingår i: Journal of Biological Chemistry. - : Elsevier BV. - 0021-9258 .- 1083-351X. ; 298:8
-
Tidskriftsartikel (refereegranskat)abstract
- Remdesivir and molnupiravir have gained considerable interest because of their demonstrated activity against SARS-CoV-2. These antivirals are converted intracellularly to their active triphosphate forms remdesivir-TP and molnupiravir-TP. Cellular hydrolysis of these active metabolites would consequently decrease the efficiency of these drugs; however, whether endogenous enzymes that can catalyze this hydrolysis exist is unknown. Here, we tested remdesivir-TP as a substrate against a panel of human hydrolases and found that only Nudix hydrolase (NUDT) 18 catalyzed the hydrolysis of remdesivir-TP with notable activity. The kcat/Km value of NUDT18 for remdesivir-TP was determined to be 17,700 s−1M−1, suggesting that NUDT18-catalyzed hydrolysis of remdesivir-TP may occur in cells. Moreover, we demonstrate that the triphosphates of the antivirals ribavirin and molnupiravir are also hydrolyzed by NUDT18, albeit with lower efficiency than Remdesivir-TP. Low activity was also observed with the triphosphate forms of sofosbuvir and aciclovir. This is the first report showing that NUDT18 hydrolyzes triphosphates of nucleoside analogs of exogenous origin, suggesting that NUDT18 can act as a cellular sanitizer of modified nucleotides and may influence the antiviral efficacy of remdesivir, molnupiravir, and ribavirin. As NUDT18 is expressed in respiratory epithelial cells, it may limit the antiviral efficacy of remdesivir and molnupiravir against SARS-CoV-2 replication by decreasing the intracellular concentration of their active metabolites at their intended site of action.
|
|
| 6. |
- John, Juliane, 1987-
(författare)
-
High (valent) on O2 : Ribonucleotide Reductase and Methane Monooxygenase
- 2023
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- Macromolecular X-ray crystallography (MX) is a powerful method to investigate protein structures. However, proteins with redox-active centres and radicals are very susceptible to photoreduction. It is therefore challenging to acquire structural details of redox-active centres in defined oxidation states or protein radicals using synchrotron radiation. Serial femtosecond crystallography (SFX) using X-ray free electron laser (XFEL) radiation mitigates this problem. XFELs produce intense pulses of femtosecond length that give rise to diffraction before photoinduced movement can occur in the illuminated protein. Additionally, SFX allows experiments at room temperature and induction of reactions in crystallo. In this thesis two different redox-active enzyme systems were investigated with MX and SFX. The first part examines ribonucleotide reductase (RNR). RNR is the only known enzyme to synthesize de novo deoxyribonucleotides, the building blocks of DNA. Class I RNR consists of a small subunit R2 and a large subunit R1. R2 generates a radical in an oxygen dependent way and delivers it to R1 for ribonucleotide reduction. After catalysis the radical is transferred back to R2 until further use. Class I RNR is divided in five subclasses, mostly based on their mechanism of radical generation. In Paper I class Ib R2 is investigated. R2b binds two manganese ions that react with superoxide to produce a radical. The superoxide is provided by a small flavoprotein, NrdI, bound to R2. When exposed to molecular oxygen, reduced NrdI generates superoxide that is transferred to the R2 active site. Here two SFX structures of reduced and oxidized NrdI in complex with R2 are presented and it is suggested how the binding and NrdI oxidation state could influence the superoxide production. In Paper II the SFX structure of a R2e protein radical is presented. Class Ie R2 contains a metal-free active site. The comparison of the radical structure with a ground state structure highlights the changes induced by radical formation. A mechanism for the initiation of the radical transfer to R1 is proposed based on the structural details observed. In Paper III light is shed on a new variant of R2e. Three of the typically conserved active site residues are mutated in R2e; from three glutamates to valine, proline and lysine (VPK) or to glutamine, serine and lysine (QSK). Other publications, including Paper II, describe the VPK mutation but as of now the QSK variant has not been examined. Here, crystal structures of a R2e QSK protein are shown. A tyrosine close to the active site is post-translationally modified to a dihydroxyphenylalanine (DOPA). The amount of modified protein is shown to scale with the coexpression of other proteins of the RNR operon. The second redox-active enzyme investigated is soluble methane monooxygenase (sMMO). sMMO oxidizes methane to methanol and is produced by methanotrophs; bacteria that use methane as their sole carbon source. Methane is a potent greenhouse gas and can be found in ever increasing concentrations in the atmosphere due to human activities; sMMO is thus a compelling target for biotechnological development. Paper IV presents SFX structures of the catalytic subunit MMOH in complex with its small regulatory subunit MMOB in the oxidized and reduced resting state. It is also demonstrated that the complex can undergo the catalytic cycle in crystallo, allowing investigation of reaction cycle intermediates in the future.
|
|
| 7. |
- Kinsolving, Julia, et al.
(författare)
-
Structural and functional insight into the interaction of Clostridioides difficile toxin B and FZD7
- 2024
-
Ingår i: Cell Reports. - 2211-1247. ; 43:2
-
Tidskriftsartikel (refereegranskat)abstract
- The G protein -coupled receptors of the Frizzled (FZD) family, in particular FZD1,2,7, are receptors that are exploited by Clostridioides difficile toxin B (TcdB), the major virulence factor responsible for pathogenesis associated with Clostridioides difficile infection. We employ a live -cell assay examining the affinity between full-length FZDs and TcdB. Moreover, we present cryoelectron microscopy structures of TcdB alone and in complex with full-length FZD7, which reveal that large structural rearrangements of the combined repetitive polypeptide domain are required for interaction with FZDs and other TcdB receptors, constituting a first step for receptor recognition. Furthermore, we show that bezlotoxumab, an FDA -approved monoclonal antibody to treat Clostridioides difficile infection, favors the apo-TcdB structure and thus disrupts binding with FZD7. The dynamic transition between the two conformations of TcdB also governs the stability of the pore -forming region. Thus, our work provides structural and functional insight into how conformational dynamics of TcdB determine receptor binding.
|
|
| 8. |
- Košenina, Sara, et al.
(författare)
-
Crystal structure of the OrfX1–OrfX3 complex from the PMP1 neurotoxin gene cluster
- 2023
-
Ingår i: FEBS Letters. - : Wiley. - 0014-5793 .- 1873-3468. ; 597:4, s. 515-523
-
Tidskriftsartikel (refereegranskat)abstract
- Paraclostridial mosquitocidal protein 1 (PMP1) is a member of the clostridial neurotoxin (CNT) family, which includes botulinum and tetanus neurotoxins. PMP1 has unique selectivity for anopheline mosquitos and is the only known member of the family that targets insects. PMP1 is encoded in an orfX gene cluster, which in addition to the toxin, consists of OrfX1, OrfX2, OrfX3, P47 and NTNH, which have been shown to aid in PMP1 toxicity. We here show that OrfX1 and OrfX3 form a complex and present its structure at 2.7 Å. The OrfX1–OrfX3 complex mimics the structure of full-length OrfX2 and belongs to the lipid-binding TULIP protein superfamily. With this report, the structures of all proteins encoded in the orfX gene cluster of CNTs are now determined.
|
|
| 9. |
- Kosenina, Sara, et al.
(författare)
-
Structural Analysis of Botulinum Neurotoxins Type B and E by Cryo-EM
- 2022
-
Ingår i: Toxins. - : MDPI AG. - 2072-6651 .- 2072-6651. ; 14:1
-
Tidskriftsartikel (refereegranskat)abstract
- Botulinum neurotoxins (BoNTs) are the causative agents of a potentially lethal paralytic disease targeting cholinergic nerve terminals. Multiple BoNT serotypes exist, with types A, B and E being the main cause of human botulism. Their extreme toxicity has been exploited for cosmetic and therapeutic uses to treat a wide range of neuromuscular disorders. Although naturally occurring BoNT types share a common end effect, their activity varies significantly based on the neuronal cell-surface receptors and intracellular SNARE substrates they target. These properties are the result of structural variations that have traditionally been studied using biophysical methods such as X-ray crystallography. Here, we determined the first structures of botulinum neurotoxins using single-particle cryogenic electron microscopy. The maps obtained at 3.6 and 3.7 Å for BoNT/B and /E, respectively, highlight the subtle structural dynamism between domains, and of the binding domain in particular. This study demonstrates how the recent advances made in the field of single-particle electron microscopy can be applied to bacterial toxins of clinical relevance and the botulinum neurotoxin family in particular.
|
|
| 10. |
- Košenina, Sara, 1993-, et al.
(författare)
-
The cryo-EM structure of the BoNT/Wo-NTNH complex reveals two immunoglobulin-like domains
- 2024
-
Ingår i: The FEBS Journal. - 1742-464X .- 1742-4658. ; 291:4, s. 676-689
-
Tidskriftsartikel (refereegranskat)abstract
- The botulinum neurotoxin-like toxin from Weissella oryzae (BoNT/Wo) is one of the BoNT-like toxins recently identified outside of the Clostridium genus. We show that, like the canonical BoNTs, BoNT/Wo forms a complex with its non-toxic non-hemagglutinin (NTNH) partner, which in traditional BoNT serotypes protects the toxin from proteases and the acidic environment of the hosts' guts. We here report the cryo-EM structure of the 300 kDa BoNT/Wo-NTNH/Wo complex together with pH stability studies of the complex. The structure reveals molecular details of the toxin's interactions with its protective partner. The overall structural arrangement is similar to other reported BoNT-NTNH complexes, but NTNH/Wo uniquely contains two extra bacterial immunoglobulin-like (Big) domains on the C-terminus. Although the function of these Big domains is unknown, they are structurally most similar to bacterial proteins involved in adhesion to host cells. In addition, the BoNT/Wo protease domain contains an internal disulfide bond not seen in other BoNTs. Mass photometry analysis revealed that the BoNT/Wo-NTNH/Wo complex is stable under acidic conditions and may dissociate at neutral to basic pH. These findings established that BoNT/Wo-NTNH/Wo shares the general fold of canonical BoNT–NTNH complexes. The presence of unique structural features suggests that it may have an alternative mode of activation, translocation and recognition of host cells, raising interesting questions about the activity and the mechanism of action of BoNT/Wo as well as about its target environment, receptors and substrates.
|
|
